Skip to main content
. 2017 Apr 8;14(4):367–375. doi: 10.7150/ijms.18288

Table 3.

Th1/Th2 specific cytokine production.

Placebo (n = 10) GM-CSF (n = 10) p-value
IL-2 [pg/mL]
od 152 (146-271) 223 (100-481) 1.000
pod1 121 (81-172) 231 (90-354) 0.181
pod2 110 (79-216) 190 (117-414) 0.073
pod3 137 (79-199) 245 (112-467) 0.138
pod4 152 (133-207) 176 (77-505) 0.699
pod5 168 (109-223) 233 (123-415) 0.366
IL-4 [pg/mL]
od 3.0 (2.0-12.0) 2.5 (2.0-9.8) 0.731
pod1 7.0 (2.0-12.0) 6.5 (2.0-28.8) 1.000
pod2 4.0 (2.0-11.0) 8.0 (3.5-21.3) 0.295
pod3 7.0 (2.0-13.0) 8.5 (5.0-19.0) 0.731
pod4 8.0 (5.3-16.3) 10.5 (2.0-17.3) 1.000
pod5 2.0 (2.0-9.0) 9.0 (4.3-14.3) 0.234
IL-5 [pg/mL]
od 6.0 (2.0-26.0) 23.5 (2.0-33.8) 0.628
pod1 9.0 (4.0-65.0) 19.5 (5.5-69.3) 0.628
pod2 5.0 (3.0-31.0) 11.0 (2.8-29.8) 0.836
pod3 11.0 (7.0-20.0) 26.5 (2.0-59.8) 0.628
pod4 11.0 (5.3-28.0) 15.0 (3.5-38.8) 1.000
pod5 7.0 (4.0-17.0) 14.0 (7.3-48.3) 0.534
IL-10 [pg/mL]
od 71 (34-91) 90 (37-130) 0.731
pod1 80 (46-136) 86 (59-131) 0.731
pod2 48 (40-104) 86 (39-148) 0.628
pod3 56 (32-72) 75 (51-125) 0.445
pod4 47 (32-115) 100 (50-112) 0.394
pod5 39 (30-67) 89 (58-143) 0.101
IFN-γ [pg/mL]
od 757 (275-1,784) 1,553 (721-3,594) 0.295
pod1 296 (95-1,045) 509 (166-719) 1.000
pod2 259 (163-1,084) 587 (191-913) 1.000
pod3 374 (88-1,237) 765 (491-986) 0.295
pod4 318 (230-1,719) 509 (281-1,462) 0.589
pod5 345 (43-1,874) 724 (289-1,268) 0.628
TNF-α [pg/mL]
od 378 (107-468) 571 (220-710) 0.234
pod1 110 (18-202) 167 (82-272) 0.628
pod2 70 (39-105) 162 (31-242) 0.534
pod3 116 (87-154) 167 (117-245) 0.366
pod4 152 (78-370) 116 (78-292) 0.818
pod5 209 (29-573) 193 (155-274) 1.000

Continuous quantities in median (25%-75% percentiles); od, day of surgery before surgery; pod, day after surgery